Preparation and Evaluation of Carbamazepine Particles Loaded in Mucoadhesive Film for Treatment of Trigeminal Neuralgia

The trigeminal nerve is the largest craniofacial nerve, responsible for detecting sensory stimuli originating from the cranial and facial areas. Trigeminal neuralgia is a common form of craniofacial neuropathic pain that causes one of the most severe pain episodes a person can endure. The pain attac...

Full description

Saved in:
Bibliographic Details
Main Authors: Fatemeh Ahmadi (Author), Mohammad Reza Mazloomi (Author), Elahehnaz Parhizkar (Author)
Format: Book
Published: Shiraz University of Medical Sciences, 2024-09-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_f6b34f0934e446cfab4d5b4e2bdad2a3
042 |a dc 
100 1 0 |a Fatemeh Ahmadi  |e author 
700 1 0 |a Mohammad Reza Mazloomi  |e author 
700 1 0 |a Elahehnaz Parhizkar  |e author 
245 0 0 |a Preparation and Evaluation of Carbamazepine Particles Loaded in Mucoadhesive Film for Treatment of Trigeminal Neuralgia 
260 |b Shiraz University of Medical Sciences,   |c 2024-09-01T00:00:00Z. 
500 |a 2423-5652 
500 |a 10.30476/tips.2024.100320.1214 
520 |a The trigeminal nerve is the largest craniofacial nerve, responsible for detecting sensory stimuli originating from the cranial and facial areas. Trigeminal neuralgia is a common form of craniofacial neuropathic pain that causes one of the most severe pain episodes a person can endure. The pain attacks would impact quality of life and mental health of patients. Carbamazepine and oxcarbazepine are recommended as first-line treatments to control pain in patients with trigeminal neuralgia. Oral administration of the mentioned drugs requires higher doses and as a result, higher risk of side effects due to the metabolic processes. Local mucosal drug delivery might be a proper alternative for oral systemic therapy in order to localize the treatment and reduce the side effects. The goal of this study was to develop an oral film containing particles of carbamazepine for treatment of trigeminal neuralgia. Particles were prepared by solvent evaporation method using chloroform and dichloromethane as organic solvents and ethyl cellulose and hydroxypropyl methylcellulose as coating polymers. The optimized particle contained equal weight ratios of polymers and was prepared using chloroform. The particles released about 70% of carbamazepine content within an hour. Optimized particles were loaded in an oral film containing 5% acacia, 10% gelatin as the film-forming polymers, and 1% glycerol and 10% PEG 400 as plasticizers. Satisfactory results were obtained from evaluation of physical characteristics of carbamazepine loaded film including: peak load was equal to 1506 mN, average thickness was 0.49 ± 0.003 mm and average weight was 1.53 ± 0.005 g. Film was completely dissolved in water. Also, release of the pure and coated drug from the optimized film was about 55% and 30%, respectively within 1 hour and about 42% and 80%, respectively after 2 hours. These preliminary results indicate that polymeric film containing particles can be a potentially successful system for delivery of carbamazepine to the oral mucosa. 
546 |a EN 
690 |a oral film 
690 |a carbamazepine 
690 |a trigeminal neuralgia 
690 |a mucoadhesive 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Trends in Pharmaceutical Sciences, Vol 10, Iss 3, Pp 215-222 (2024) 
787 0 |n https://tips.sums.ac.ir/article_50351_f9a319a7aad9f6c04342434b0ac89a41.pdf 
787 0 |n https://doaj.org/toc/2423-5652 
856 4 1 |u https://doaj.org/article/f6b34f0934e446cfab4d5b4e2bdad2a3  |z Connect to this object online.